SE7907939L - Terapeutiskt aktiva polypeptider eller syraadditionssalter derav och forfaringssett for framstellning av sadana foreningar - Google Patents

Terapeutiskt aktiva polypeptider eller syraadditionssalter derav och forfaringssett for framstellning av sadana foreningar

Info

Publication number
SE7907939L
SE7907939L SE7907939A SE7907939A SE7907939L SE 7907939 L SE7907939 L SE 7907939L SE 7907939 A SE7907939 A SE 7907939A SE 7907939 A SE7907939 A SE 7907939A SE 7907939 L SE7907939 L SE 7907939L
Authority
SE
Sweden
Prior art keywords
amino acid
group
glucose
addition salts
acid addition
Prior art date
Application number
SE7907939A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
H Kofod
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of SE7907939L publication Critical patent/SE7907939L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/645—Secretins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7907939A 1978-09-28 1979-09-25 Terapeutiskt aktiva polypeptider eller syraadditionssalter derav och forfaringssett for framstellning av sadana foreningar SE7907939L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK430478 1978-09-28

Publications (1)

Publication Number Publication Date
SE7907939L true SE7907939L (sv) 1980-03-29

Family

ID=8132257

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7907939A SE7907939L (sv) 1978-09-28 1979-09-25 Terapeutiskt aktiva polypeptider eller syraadditionssalter derav och forfaringssett for framstellning av sadana foreningar
SE7907938A SE7907938L (sv) 1978-09-28 1979-09-25 Terapeutiskt aktiva polypeptider eller syraadditionssalter och forfaringssett for framstellning av sadana foreningar

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7907938A SE7907938L (sv) 1978-09-28 1979-09-25 Terapeutiskt aktiva polypeptider eller syraadditionssalter och forfaringssett for framstellning av sadana foreningar

Country Status (16)

Country Link
US (1) US4356119A (de)
JP (2) JPS5569550A (de)
AT (1) AT375338B (de)
AU (2) AU526149B2 (de)
BE (2) BE879086A (de)
CA (2) CA1158640A (de)
CH (2) CH648568A5 (de)
DE (2) DE2939109A1 (de)
ES (2) ES484926A1 (de)
FI (2) FI68244C (de)
FR (2) FR2437400A1 (de)
GB (2) GB2031435B (de)
IT (2) IT1125422B (de)
NL (2) NL7907188A (de)
NO (2) NO148923C (de)
SE (2) SE7907939L (de)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA616330A (en) * 1961-03-14 Schwyzer Robert Polypeptide and derivatives thereof and process for their manfuacture
CA798855A (en) * 1968-11-12 Bernardi Luigi Process for preparing a new undecapeptide
CA685075A (en) * 1964-04-21 Schwyzer Robert Polypeptides and process for their manufacture
GB1064417A (en) * 1963-12-09 1967-04-05 Kyowa Hakko Kogyo Kk Process for the preparation of copolypeptides
US3400118A (en) * 1966-05-27 1968-09-03 Squibb & Sons Inc Intermediates in the preparation of secretin
US3832337A (en) * 1970-07-28 1974-08-27 Squibb & Sons Inc Peptide enzyme inhibitors
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175988C (nl) * 1972-05-24 1985-02-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2315271C3 (de) * 1973-03-27 1975-09-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4110321A (en) * 1976-07-12 1978-08-29 Folkers Karl Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity
US4086220A (en) * 1976-08-09 1978-04-25 G. D. Searle & Co. Fragments of secretin

Also Published As

Publication number Publication date
GB2031435B (en) 1982-11-10
NL7907188A (nl) 1980-04-01
NL7907187A (nl) 1980-04-01
CA1140116A (en) 1983-01-25
NO793111L (no) 1980-03-31
AU5124579A (en) 1980-04-03
FI793001A (fi) 1980-03-29
BE879087A (fr) 1980-03-28
BE879086A (fr) 1980-03-28
NO148922B (no) 1983-10-03
NO148922C (no) 1984-01-11
NO148923C (no) 1984-01-11
NO793112L (no) 1980-03-31
IT7926112A0 (it) 1979-09-28
FI68244B (fi) 1985-04-30
FI793002A (fi) 1980-03-29
JPS5576849A (en) 1980-06-10
JPS5569550A (en) 1980-05-26
IT1125422B (it) 1986-05-14
AU526149B2 (en) 1982-12-16
CH648568A5 (de) 1985-03-29
CA1158640A (en) 1983-12-13
DE2939109A1 (de) 1980-04-10
ES484928A1 (es) 1980-07-01
FR2437400A1 (fr) 1980-04-25
IT7926111A0 (it) 1979-09-28
CH648567A5 (de) 1985-03-29
DE2939135A1 (de) 1980-04-17
AT375338B (de) 1984-07-25
FR2437399A1 (fr) 1980-04-25
FI68245C (fi) 1985-08-12
FI68245B (fi) 1985-04-30
AU533684B2 (en) 1983-12-08
FR2437400B1 (de) 1984-06-15
GB2031435A (en) 1980-04-23
FI68244C (fi) 1985-08-12
ATA634679A (de) 1983-12-15
AU5124679A (en) 1980-04-03
GB2031436A (en) 1980-04-23
GB2031436B (en) 1982-10-20
IT1125421B (it) 1986-05-14
NO148923B (no) 1983-10-03
US4356119A (en) 1982-10-26
SE7907938L (sv) 1980-03-29
ES484926A1 (es) 1980-07-01
FR2437399B1 (de) 1983-01-28

Similar Documents

Publication Publication Date Title
US4608364A (en) Pharmaceutical agent for the treatment of diabetes mellitus
ES2326707T3 (es) Tripeptidos inhibidores de la hepatitis c.
ES2611040T3 (es) Derivados de insulina
ES8504749A1 (es) Procedimiento para preparar derivados de tiazol
DE58909633D1 (de) Neue Insulinderivate, Verfahren zu deren Herstellung, ihre Verwendung und eine sie enthaltende pharmazeutische Zubereitung
DE58905456D1 (de) Neue Insulinderivate, ihre Verwendung und eine sie enthaltende pharmazeutische Zubereitung.
FI842166A (fi) Bukspottskoertelns grf hos maenniskan.
IE39528B1 (en) Pharmaceutically active peptides and method of use thereof
SE425715B (sv) Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdom
CA2167167A1 (en) Hydrazino-type radionuclide chelators having an n3s configuration
AR008269A1 (es) Derivados de insulina con unión a zinc incrementada, un complejo, una composición farmacéutica y proinsulina.
DK149091C (da) Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf
SE7907939L (sv) Terapeutiskt aktiva polypeptider eller syraadditionssalter derav och forfaringssett for framstellning av sadana foreningar
Sundby et al. Rabbit glucagon: isolation, crystallization and amino acid composition
JPS5962557A (ja) 新規ポリペプチド、その製造法および医薬
JPS6426598A (en) Calcitonin gene related peptide derivative
NZ241029A (en) Peptides with cysteine residue or dimers thereof with insulin activity and pharmaceutical compositions
FR2382433A1 (fr) Analogues de somatostatine et leur preparation
SE7706567L (sv) Biologiskt aktiva peptider
Li Synthetic Somatomedin C/Insulinlike Growth Factor I
JPS5283749A (en) Novel polypeptide
NL7801943A (en) Somatostatin peptide analogues - which inhibit somatotropin, glucagon and/or insulin release and can be used for treating acromegaly or diabetes
ES8105699A1 (es) Un metodo para aislar un polipeptido espasmolitico pancreatico purificado.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7907939-8

Format of ref document f/p: F